RITALIN vs VYVANSE
Independent side-by-side comparison.
Both are Schedule II CNS stimulants approved for ADHD, and they carry the same boxed warning. They are closer than the internet suggests; the choice belongs to your prescriber.
The key difference
One difference that matters is what else each label is approved for. Ritalin covers ADHD (age 6 and up, and adults) and narcolepsy. Vyvanse covers ADHD and moderate to severe binge eating disorder in adults — and states it is not indicated for weight loss. A diagnosis outside ADHD can decide this on its own.
They also differ in shape of use: Ritalin is immediate-release, taken more than once a day; Vyvanse is a prodrug of dextroamphetamine taken once every morning, with a lower ceiling in severe kidney impairment.
Both carry the same boxed warning — ABUSE, MISUSE, AND ADDICTION — and both state that misuse and abuse of CNS stimulants can result in overdose and death, more so at higher doses or if snorted or injected. Both warn about serious cardiac disease and sudden death and call for a cardiac history and exam before starting. Both are contraindicated with an MAOI, or within 14 days of stopping one, because of hypertensive crisis. Neither should be stopped abruptly after prolonged use without a prescriber: both describe withdrawal including depression and dysphoric mood.
What favours Ritalin (methylphenidate)
Ritalin's label is the one that covers narcolepsy — Vyvanse's does not. Doses spread through the day also let a prescriber shape coverage around school or work hours rather than committing to a single morning dose.
What favours Vyvanse (lisdexamfetamine)
Vyvanse's label is the one that covers moderate to severe binge eating disorder in adults — Ritalin's does not. It is also the once-every-morning option, which matters when a mid-day dose is impractical (though its label lowers the maximum in severe kidney impairment).
Bottom line
For plain ADHD these two are more alike than different: same class, same schedule, same boxed warning about abuse, misuse and addiction, same cardiac screening before you start, same MAOI contraindication. The decider is usually something written on the label rather than one drug being "better" — narcolepsy points to Ritalin, binge eating disorder in an adult points to Vyvanse, and beyond that your prescriber is matching dosing pattern, heart history, kidney function and how you actually respond. Do not start, stop or re-dose either on your own; withdrawal after prolonged use is a labelled effect. We sell neither drug and no coupons for them — we rate them on their FDA recall record — which is why we can say "ask your doctor" instead of steering you.
This is not a summary of either drug’s FDA label, and it is not complete. Both labels carry warnings, contraindications and interactions that are not on this page. Read the label for the drug you are actually taking — we link both above — and take the decision to your prescriber.
Possible drug interaction. RITALIN and VYVANSE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.
Rating
Pharmacy pays
Type
Active ingredient
Manufacturer
Dosage forms
Drug class
Boxed warning
Half-life
Treats
Frequently asked questions
What is the difference between Ritalin and Vyvanse?
Ritalin contains Methylphenidate Hydrochloride, while Vyvanse contains Lisdexamfetamine Dimesylate — they have different active ingredients.
Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.